Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries’ one of the wholly owned subsidiaries has agreed to acquire by way of allotment to it, 428,571 ordinary shares (equivalent to 12.5% fully diluted equity stake) of WRS Bioproducts Pty, Australia. WRS Bioproducts Pty develops novel technologies to produce and commercialize supplements and nutraceutical ingredients from diverse algae species in Australia.

Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.